StockNews.AI
PETS
StockNews.AI
62 days

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS

1. PetMed Express is under investigation for potential securities fraud. 2. The company delayed its fiscal year 2025 earnings release. 3. PetMed's stock dropped by 11.22% following the announcement. 4. Pomerantz LLP is leading the class action investigation for investors. 5. Investors advised to contact Pomerantz LLP regarding potential claims.

3m saved
Insight
Article

FAQ

Why Very Bearish?

The stock drop of 11.22% signals significant investor concern post-announcement. Similar historical instances show prolonged declines in stocks under SEC investigations.

How important is it?

The allegations against PetMed could significantly impact reputation and future earnings guidance, affecting stock valuation. Delays in financial reporting often lead to regulatory scrutiny.

Why Short Term?

Immediate investor sentiment may not recover until investigations clarify the situation. Past cases show rapid price recovery only after resolution or clarity is provided.

Related Companies

CLOVGRMNMDLZ
NEW YORK, June 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether PetMed and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On June 10, 2025, PetMed issued a press release “announc[ing] it is delaying the release of the Company’s fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process.”  On this news, PetMed’s stock price fell $0.47 per share, or 11.22%, to close at $3.72 per share on June 11, 2025. The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, London, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com. Attorney advertising.  Prior results do not guarantee similar outcomes.  CONTACT:Danielle PeytonPomerantz LLPdpeyton@pomlaw.com646-581-9980 ext. 7980

Related News